Showing 191-200 of 2293 results for "".
Headache Disorders: Acute Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-disorders-acute-management/31768/A case-based approach to navigating special situations in acute management of headache disorders in the neurology clinic.Neuromuscular Notes: Neuromuscular Ultrasound in Polyneuropathy
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neuromuscular-notes-neuromuscular-ultrasound-in-polyneuropathy/31677/A standardized evidence-based and expert approach to ultrasound for diagnosis of polyneuropathy is described.Monitoring Disease Course and Treatment Response in Various Populations With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/monitoring-disease-course-and-treatment-response-in-various-populations-with-multiple-sclerosis/33144/Monitoring for signs of disease activity or progression in multiple sclerosis—a crucial component of disease management—may need refinement for pediatric, pregnant or postpartum, older, and minority or underserved populations.Multiple Sclerosis Minute: Natalizumab Extended-Interval Dosing
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-natalizumab-extended-interval-dosing/31647/The extended interval dosing approach for natalizumab treatment reduces the risk of progressive multifocal leukoencephalopathy.Ultrasound in Neuromuscular Medicine
https://practicalneurology.com/diseases-diagnoses/neuromuscular/ultrasound-in-neuromuscular-medicine/31601/Ultrasound is highly useful and an integrated complement to history, physical exam, and electrodiagnostic testing for neuromuscular disease.Epilepsy Essentials: In-Home EEG During the COVID-19 Pandemic
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-inhome-eeg-during-the-covid19-pandemic/31678/A pandemic gives us cause to reconsider strengths and limitations of in-home EEG.Treating Early Relapsing Multiple Sclerosis: Induction & Escalation Approaches
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treating-early-relapsing-multiple-sclerosis-induction-escalation-approaches/31873/Evidence-based clinical trial results are needed to guide this difficult decision-making processUpdates in Bruton Tyrosine Kinase Inhibition for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/updates-in-bruton-tyrosine-kinase-inhibition-for-multiple-sclerosis/31975/Ongoing clinical trials will elucidate potential advantages and safety of these novel medications for future treatment of multiple sclerosis.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31195/Early Intervention in Multiple Sclerosis: Insights from Clinical TrialsInitiating treatment promptly after the first demyelinating event, known as a clinically isolated syndrome (CIS), is increasingly supported by robust scientific evidence. Dr. Patricia Coyle, Professor and Acting Chair of Neurolog
Quantitative Structural MRI for Neurocognitive Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/quantitative-structural-mri-for-neurocognitive-disorders/31730/Alzheimer disease dementia, frontotemporal dementia, and traumatic brain injury can be differentiated with quantitative MRI.